Opioid Policies
Much like the rest of the United States, residents of the District of Columbia are struggling with substance use disorder (SUD) rate increases and high rates of opioid-related deaths. Unfortunately, these are multi-faceted issues that require year-long initiatives and systematic programs to address the myriad causes of addiction.
MSDC stands as a partner to the District government and private entities to help arrest the rates of opioid and substance abuse in the District. Through our advocacy for better prescribing practices, education on addiction, and even helping our own community through our Physician Health Program, MSDC is working to make DC a leader in reducing SUD, OUD, and addiction.
On a related note, MSDC is passionate about helping patients make prescriptions and medication more affordable. Whether expanding access to biosimilars or advocating for more affordable co-pays, MSDC wants to help our patients afford the medications they need.
MSDC Statement and Testimony on Opioid and Prescription Issues
25th Council information coming soon
-
2022 Looks to Be A Very Busy Year in Physician AdvocacyJanuary 4, 2022
Physicians will need to be strong advocates for and against the major issues MSDC expects the DC Council to debate this calendar year.
Continue Reading -
MSDC’s 2021 Annual Report Showcases DC Physician AchievementsDecember 28, 2021
MSDC’s 2021 accomplishments include increased physician wellbeing resources, major advocacy wins, and a growing and active physician membership. See the brief 2021 Annual Report video and 2021 highlights.
Continue Reading -
Advocacy Curriculum: Looking Back on 2021 Year in Advocacy
December 21, 2021
This year saw some major wins in the physician agenda as well as the introduction of new tools to help with advocacy.
Continue Reading -
MSDC Board Looks Back on Productive Past and Ahead to Bright FutureDecember 14, 2021
The MSDC Board met for the last time in 2021 to meet with special guests and plan for the upcoming year.
Continue Reading
Sample of Legislation MSDC Tracked on Opioid and Prescription Policy
What does it do? The bill authorizes licensed pahrmacists to dispense interchangeable biological products and requires notifications to physicians when such interchangeables are dispensed.
MSDC position: MSDC has a position of priority support on this legislation, identifying its passage as one of its highest legislative priorities.
Current status: SUCCESS. The bill was passed by the Council and signed by the Mayor.
What does it do? The bill requires prescription opioid medications to include a statement that the drug is an opioid and opioids may cause dependence, addiction, or overdoes.
MSDC position: MSDC supports the legislation.
Current status: The bill had a hearing before the Committee on Health on July 29, 2020. MSDC leader Dr. Sam Kareff testified for the Medical Society. It passed the Council on November 10 and was signed by the Mayor December 7.
What does it do? The bill prohibits insurance companies from factoring the use of PreP in decisions related to disability, life, or long-term care policies.
MSDC position: MSDC supports this legislation
Current status: The bill was introduced on January 8, 2019 and assigned to the Committee on Business and Economic Development.